Development of thymic tumor in [LSL:Kras(G12D); Pdx1-CRE] mice, an adverse effect associated with accelerated pancreatic carcinogenesis

Pancreatic Ductal AdenoCarcinoma (PDAC) represents about 90% of pancreatic cancers. It is one of the most aggressive cancer, with a 5-year survival rate below 10% due to late diagnosis and poor therapeutic efficiency. This bad prognosis thus encourages intense research in order to better understand...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Liot, Sophie, El Kholti, Naïma, Balas, Jonathan, Genestier, Laurent, Verrier, Bernard, Valcourt, Ulrich, Lambert, Elise
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8302691/
https://ncbi.nlm.nih.gov/pubmed/34302028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-94566-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados